Curis
CRIS
#10201
Rank
NZ$30.21 M
Marketcap
NZ$2.34
Share price
0.00%
Change (1 day)
-65.20%
Change (1 year)

Curis (CRIS) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$47.84 Million

According to Curis's latest financial reports the company's total assets are NZ$47.84 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Curis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$73.16 M-40.13%
2023-12-31NZ$0.12 B-28.72%
2022-12-31NZ$0.17 B-27.85%
2021-12-31NZ$0.23 B-16.1%
2020-12-31NZ$0.28 B443.33%
2019-12-31NZ$52.12 M-6.42%
2018-12-31NZ$55.7 M-46.39%
2017-12-31NZ$0.10 B24.63%
2016-12-31NZ$83.37 M-39.91%
2015-12-31NZ$0.13 B73.63%
2014-12-31NZ$79.91 M-18.51%
2013-12-31NZ$98.07 M15.64%
2012-12-31NZ$84.81 M37.38%
2011-12-31NZ$61.73 M-5.97%
2010-12-31NZ$65.65 M32.09%
2009-12-31NZ$49.7 M-27.86%
2008-12-31NZ$68.89 M-1.94%
2007-12-31NZ$70.25 M-5.3%
2006-12-31NZ$74.19 M-16.75%
2005-12-31NZ$89.12 M-5.55%
2004-12-31NZ$94.36 M10.05%
2003-12-31NZ$85.74 M-28.14%
2002-12-31NZ$0.11 B-65.77%
2001-12-31NZ$0.34 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Exelixis
EXEL
NZ$4.88 B 10,115.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.52 B 5,185.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$0.18 B 289.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.12 B 2,245.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 755,049.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 350,426.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$35.2 M-26.43%๐Ÿ‡บ๐Ÿ‡ธ USA